Glendon Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-400,709
Closed -$12.7M 23
2021
Q1
$12.7M Sell
400,709
-53,801
-12% -$1.58M 1.33% 14
2020
Q4
$9.45M Sell
454,510
-49,509
-10% -$923K 1.53% 12
2020
Q3
$7.83M Sell
504,019
-18,626
-4% -$321K 1.67% 13
2020
Q2
$9.56M Hold
522,645
2.52% 8
2020
Q1
$8.1M Hold
522,645
2.65% 9
2019
Q4
$15.6M Buy
522,645
+120,000
+30% +$3.12M 3.64% 8
2019
Q3
$8.8M Buy
402,645
+297,645
+283% +$6.81M 2.03% 10
2019
Q2
$2.65M Buy
+105,000
New +$2.49M 0.62% 15

Other funds holding BHC

Glendon Capital Management's BHC Position: Q2 2021 in Review

Glendon Capital Management sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 400,709 shares — an estimated $12.7M sold.

Glendon Capital Management first reported a position in BHC in Q2 2019 and held it in 8 quarters. The position peaked at $15.6M in Q4 2019. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • Glendon Capital Management reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • Glendon Capital Management sold 400,709 Bausch Health shares in Q2 2021, an estimated $12.7M.
  • Glendon Capital Management first reported a position in Bausch Health in Q2 2019 and held it in 8 quarters.
  • Glendon Capital Management's Bausch Health position peaked at $15.6M in Q4 2019.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Glendon Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.